Doctor profile · Federal record
Dr. John Stewart, M.D.
Dermatology Physician (CMS: Dermatology) · Opelika, AL
- NPI 1265423313
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 50 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
122 N 20Th St, Bldg 25
Opelika, AL 368015442
(334) 749-5604
fax (334) 749-3040
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- August 10, 2021
- Year of graduation
- 1976 — 50 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Alabama #00009216
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265423313. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,419
Distinct HCPCS
10
Medicare allowed
$433,705
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 6,759 | 582 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 993 | 650 | $36 | |
17110 |
Destruction of skin growth, 1-14 growths | 596 | 463 | $79 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 490 | 353 | $84 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 419 | 90 | $1 | |
17282 |
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 381 | 226 | $150 | |
17272 |
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 235 | 156 | $122 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 187 | 120 | $104 | |
11602 |
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 119 | 85 | $182 | |
11622 |
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 91 | 70 | $200 |
In context: peer comparison
Among 1 peers in Opelika Dermatology Physician, average services per provider: 285. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$1,288
Transactions
68
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 9 | $348.60 | |
| Abbvie INC. | 18 | $334.98 | |
| Ucb, INC. | 23 | $257.03 | |
| Pfizer INC. | 5 | $95.63 | |
| Amgen INC. | 4 | $74.16 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $63.81 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.02 | |
| Genzyme Corporation | 2 | $38.66 | |
| Regeneron Healthcare Solutions, INC. | 1 | $17.69 | |
| Revance Therapeutics, INC. | 1 | $15.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,146
Patients
1,124
Total drug cost
$671,749
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 534 | 303 | $5,898 |
| Clobetasol Propionate | Generic | 307 | 166 | $17,948 |
| Fluorouracil | Generic | 232 | 160 | $22,411 |
| Ketoconazole | Generic | 161 | 85 | $3,069 |
| Minocycline Hcl | Generic | 142 | 49 | $2,803 |
| Desonide | Generic | 99 | 50 | $11,307 |
| Doxycycline Hyclate | Generic | 97 | 59 | $1,658 |
| Fluocinonide | Generic | 92 | 55 | $6,647 |
| Fluconazole | Generic | 84 | 54 | $819 |
| Otezla (Apremilast) | Brand | 78 | 0 | $375,936 |
Hospital affiliations
Frequently asked questions
What is Dr. John Stewart's medical specialty?
Dr. John Stewart practices Dermatology Physician in Opelika, AL.
Where does Dr. John Stewart practice?
Dr. John Stewart practices at 122 N 20Th St, Opelika, AL 368015442. Office phone: 3347495604.
What is Dr. John Stewart's NPI?
Dr. John Stewart's National Provider Identifier (NPI) is 1265423313, issued by NPPES.
Does Dr. John Stewart accept Medicare assignment?
Yes. Dr. John Stewart accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Stewart commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.